DreamCIS INC.
Contract research organization for pharma, biotech, and medical device industries.
223250 | KO
Overview
Corporate Details
- ISIN(s):
- KR7223250002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 종로구 사직로 130 적선현대빌딩, 10층 10호, 서울특별시
- Website:
- https://dreamcis.com/
Description
DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-29 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 2.5 MB | ||
| 2020-04-10 00:00 |
증권신고서(지분증권)
|
Korean | 1.9 MB | ||
| 2020-04-09 00:00 |
감사보고서 (2019.12)
|
Korean | 354.3 KB |
Automate Your Workflow. Get a real-time feed of all DreamCIS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DreamCIS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DreamCIS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
